Sign in

CIK 0001622229 · Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465308248
Phone
617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Other events
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 4 Option exercise Director acquired 1,500,000 shares (option exercise)
  13. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. ARS Other Annual Report to Security Holders
  19. DEFA14A Proxy Proxy Materials
  20. DEF 14A Proxy Proxy Statement

Page 8 of 31 · 616 filings